Safety Assessment of Medication Regimen

Medication Concerns

The American College of Psychiatrists recommends that the combination of two antipsychotics, such as Aristada and clozapine, is generally not recommended due to increased risk of side effects without clear evidence of additional benefit 1
The National Institute of Mental Health suggests that clozapine is typically reserved for treatment-resistant schizophrenia, and when used, should ideally be monitored closely due to its significant side effect profile 1
The use of benzodiazepines, such as alprazolam, can lead to tolerance, addiction, depression, and cognitive impairment with regular use, according to the American Academy of Family Physicians 2
Paradoxical agitation occurs in approximately 10% of patients treated with benzodiazepines, as reported by the American Academy of Family Physicians 2
For patients aged 56, benzodiazepines carry increased risk of falls and cognitive impairment, according to the American Geriatrics Society 3

The combination of clozapine and aripiprazole lauroxil may increase the risk of sedation and central nervous system depression, as reported by The Lancet Psychiatry 1
The combination of clozapine and aripiprazole lauroxil may also increase the risk of extrapyramidal symptoms, according to the American Academy of Family Physicians 2
The use of alprazolam with clozapine may increase the risk of oversedation and respiratory depression, as reported by the Annals of Oncology 3

The American College of Psychiatrists recommends considering using either clozapine or aripiprazole lauroxil as monotherapy rather than both together 1
The National Institute of Mental Health suggests maintaining clozapine at the current dose but discontinuing Aristada, or gradually tapering and discontinuing clozapine under close supervision 1
The American Academy of Family Physicians recommends reducing or eliminating alprazolam use due to risks in this age group and medication combination 2
The Journal of the National Comprehensive Cancer Network recommends limiting alprazolam to the lowest effective dose and shortest duration possible 5

Regular monitoring should include vital signs, electrocardiogram to monitor QTc interval, assessment for extrapyramidal symptoms, sedation, and cognitive function, as recommended by the American Heart Association and the American Academy of Family Physicians 2
Evaluation for signs of respiratory depression, particularly when all three medications are used concurrently, is also recommended by the Annals of Oncology 3